Aedesius Health and AO BIO have announced a comprehensive commercialisation partnership with Indegene, a company statement said.

Through this multi-year partnership, Indegene will support the design and operationalisation around the commercial infrastructure for Aedesius Health and its projects, starting with commercialisation of several key assets in the AO BIO pipeline, the statement added.

It also said that Indegene’s co-commercialisation model enables Aedesius Health and AO BIO to achieve their mission to reset the standard for clinical development, offering innovative and strategic advanced and early access programmes of its products, and ultimate commercialisation, with end-to-end capabilities across the development to commercialisation value chain. This includes deep medical expertise and a digital-first approach to clinical operations, commercial operations, omnichannel marketing strategy and operations, medical information management systems, medical affairs, regulatory affairs, pharmacovigilance/safety, patient support, analytics, IT systems and pricing, reimbursement and market access.